Az To File Triple Combination Therapy For Copd | Latest News RSS feed

Az To File Triple Combination Therapy For Copd - Latest News


AZ to file triple combination therapy for COPD

Global Medicines at AZ, said: “We are encouraged by the results of the KRONOS trial which demonstrate PT010’s efficacy in improving lung function and its potential value as a triple combination therap... read more

AZ to file COPD combo in China and Japan

AstraZeneca is planning filings of its chronic obstructive pulmonary disease drug Bevespi Aerosphere in China and Japan ... and Chiesi has got its COPD triple therapy Trimbow approved in Europe and is ... read more

GSK Files Regulatory Submission in European Union for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD

--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the filing ... a maintenance treatment to relieve symptoms of adult patients with COPD. It is b... read more

Looking for another news?


GSK plans to file an NDA with US FDA for once-daily closed triple combo therapy FF/UMEC/VI in patients with COPD

GlaxoSmithKline plc (GSK) and Innoviva, Inc announced that, following discussions with the US Food and Drug Administration (FDA), GSK has brought forward the plan to file a New ... of the closed tripl... read more


Vertex reports early success in triple combo cystic fibrosis drug trials

Vertex Pharmaceuticals hit a new milestone in its goal to treat all cystic fibrosis patients after the company revealed interim data Tuesday indicating that its new triple combination drug helped impr... read more

AZ’ triple combo COPD inhaler hits PhIII targets

AstraZeneca recently unveiled top-line trial data backing use of an experimental triple combination therapy being ... characterise the role of this potential treatment for patients with COPD,” said AZ ... read more

Glaxo/Innoviva's Triple Combo Therapy Gets FDA Nod for COPD

This combination medicine will be delivered once daily in the Ellipta dry powder inhaler. Typically, the ICS/LAMA/LABA amalgamation for advanced COPD is ... announced filing of a regulatory submission ... read more

GSK files first application for triple COPD therapy

GlaxoSmithKline has submitted its three-in-one treatment for chronic obstructive pulmonary disease (COPD) in the US, more than a year earlier than planned. GSK had previously suggested it would file t... read more

How Will GlaxoSmithKline's Triple Therapy Combination Perform In The Market?

Potential Market Opportunity 18 percent of the COPD patients on treatment ... How much market share can GSK's triple therapy combination get ? GSK's closed triple therapy combination is expected to be ... read more

AZ boosted by COPD triple inhaler results

AZ’s single inhaler, PT010, showed statistically significant improvement in eight of nine lung ... and could file in the US and Europe next year. GlaxoSmithKline’s Trelegy is approved in the EU and US ... read more

Glaxo/Innoviva File for Approval of Trelegy Ellipta in Japan

The therapy ... photos The filing included data from the Phase III IMPACT study, evaluating the safety and effectiveness of Trelegy Ellipta in comparison to existing COPD therapies. The study revealed ... read more

Vertex rises on data for cystic fibrosis triple therapy

Vertex Pharma has the first phase 3 data from its highly-anticipated three-drug combination for cystic fibrosis (CF), setting up a possible regulatory filing ... treatment, with 12-week data due early ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us